Abstract
Cervical cancer is a serious public health issue in Brazil, often asymptomatic in its early stages and potentially invasive if left untreated. Current treatments cause side effects and face challenges related to drug resistance, highlighting the need for new therapeutic approaches. Chalcones have antineoplastic activity, while quinazolines act as tyrosine kinase inhibitors. Hybrid therapi…